ABOUT US
The National Adult Vaccination Program (NAVP), is a multi-stakeholder industry-supported collaboration to develop a cohesive strategic and policy approach to improve adult vaccination aligned with the recommendations of the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention.
ADDRESSING CONCERNS ABOUT VACCINES
Building trust and addressing social norms are keys to convincing patients to vaccinate. Learn more about vaccine confidence, how to increase it, and resources available to all health professionals.
2018 ICAMP REGISTRATION OPEN
ICAMP is a multidisciplinary program designed to equip health care professionals to champion adult immunization practices that improve public health and the quality of care for the people they serve. Trainings will be held in Dallas (March 21) as part of the AMDA conference and Boston (November 13) as part of the GSA annual scientific meeting.
NEWS AND UPDATES
CDC Released 2018 Adult Immunization Schedule
On February 6, the 2018 approved recommendations for immunization of adults age 19 and older went into effect. There are language updates for Td/Tdap, MMR, HPV, and MenACWY and new recommendations for use of herpes zoster vaccine. The comprehensive summary of the ACIP recommended changes made to the adult immunization schedule can be found in the February 6, 2018 MMWR.
CDC Releases Updated Recommendations on Shingles Vaccine
On October 23, the FDA announced its approval of Shingrix, a vaccine for prevention of shingles (herpes zoster), in adults 50 and older. On October 25, the ACIP voted to preferentially recommend the vaccine for those 50 and older. The MMWR recommendations were subsequently published on January 25, 2018. Shingrix has shown 90% efficacy across all age groups in prevention of shingles, meeting its goal to overcome age-related decline in immunity. By preventing shingles, the vaccine has also reduced incidence of post herpetic neuralgia, a painful and common complication of shingles. The vaccine is non-live and given in two doses.
New Publication Available - Addressing the Complex Impact of Immunosenescence: The Value of Vaccination
View a new What's Hot publication on the impact of age-related decline in immunity, the connection between infection and events such as heart attack and stroke, and an overview of new vaccines that have overcome immunosenescence to better protect older adults.
Aging and Immunity: The Important Role of Vaccines
View a new publication from GSA, the American College of Physicians, and American Pharmacists Association, designed to help health care professionals understand the biological impact of aging on immunity and reinforce the importance of adult immunization.
New GSA Blog and Presentations on "What Works" in Raising Adult Immunization Rates
On November 7, GSA hosted a briefing -- "Adult Immunization: Successful Programs Leading the Way to Higher Rates" focused on the positive steps health systems and communities can take right now to improve rates. The presentations from 3 successful programs and moderator R. Gordon Douglas, Jr, MD, are now available, as is a new GSA blog from CEO James Appleby on the event.
CDC Offers Toolkit for Flu Season
The 2017-2018 has begun and CDC is offering flu vaccine advocates a digital media toolkit for both flu season and National Influenza Vaccine Week (December 3-9). The toolkits include posters, fact sheets, sample social media messages, and images.